The Senate this week passed two bills to help women at high risk for breast cancer, ensuring coverage for MRIs, ultrasounds and genetic testing with no out-of-pocket costs.
Breast cancer is the second-most common cancer in women in the United States after skin cancers, and early detection is the key to saving lives. The Senate approved the following bills:
Senate Bill 1225 eliminates out-of-pocket costs for breast MRI and ultrasound for women with high-risk conditions such as dense breast tissue, a family history of breast cancer, personal history of breast cancer, genetic predisposition or prior radiation therapy.
Senate Bill 1330 removes costs associated with genetic testing and counseling for Pennsylvanians with a family history of breast and ovarian cancers. Genetic testing for heredity cancers provides the opportunity for earlier screenings and preventive treatments and procedures.
At a news conference celebrating passage of the bills, PA Breast Cancer Coalition President Pat Halpin-Murphy said: “Senate Bill 1225 and Senate Bill 1330 will arm the women of Pennsylvania with the best tools possible to find breast cancer at its earliest, most treatable stage.”